Zobrazeno 1 - 10
of 686
pro vyhledávání: '"ATOPIC KERATOCONJUNCTIVITIS"'
Publikováno v:
Российский офтальмологический журнал, Vol 17, Iss 3, Pp 35-40 (2024)
Ocular allergies are a group of diseases that affect the surface of the eye and are usually accompanied by type 1 hypersensitivity reactions. Purpose: to evaluate the clinical manifestations of allergic conjunctivitis and compare the effectiveness an
Externí odkaz:
https://doaj.org/article/5f670a5d38554d11840efa9aa4e6b159
Publikováno v:
Journal of Clinical Ophthalmology and Research, Vol 12, Iss 3, Pp 317-319 (2024)
We present a case of scleral lens surface crazing in a patient with keratoconus (KC) and chronic giant papillary conjunctivitis (GPC). A 45-year-old Asian male with known keratoconus (KC) and allergic eye disease in both eyes, who is an experienced s
Externí odkaz:
https://doaj.org/article/51fd1506449f4975b3c17a819ae5b6a2
Autor:
Yonehara, Michiko a, Nakagawa, Yuji b, Ayatsuka, Yuji b, Hara, Yuko c, Shoji, Jun d, Ebihara, Nobuyuki e, Inomata, Takenori f, g, h, Huang, Tianxiang f, Nagino, Ken f, g, Fukuda, Ken i, Kishimoto, Tatsuma i, Sumi, Tamaki i, Fukushima, Atsuki j, Fujishima, Hiroshi k, Kawai, Moeko l, Takamura, Etsuko l, Uchio, Eiichi m, Namba, Kenichi n, Koyama, Ayumi a, Haruki, Tomoko a, Sasaki, Shin-ich a, Shimizu, Yumiko a, Miyazaki, Dai a, ⁎
Publikováno v:
In Allergology International January 2025 74(1):86-96
Publikováno v:
Clinical Ophthalmology, Vol Volume 17, Pp 3271-3279 (2023)
Hideaki Fujita, Tomohiro Ueno, Shuji Suzuki, Kazuhiro Harada, Tomoko Tsukahara-Kawamura, Hiroaki Ozaki, Eiichi Uchio Department of Ophthalmology, Fukuoka University School of Medicine, Fukuoka, JapanCorrespondence: Eiichi Uchio, Department of Ophthal
Externí odkaz:
https://doaj.org/article/67c04e9763044c05a216e22643650735
Autor:
Yuka Hosotani, Koubun Yasuda, Makoto Nagai, Kiyofumi Yamanishi, Nobuo Kanazawa, Fumi Gomi, Yasutomo Imai
Publikováno v:
Allergology International, Vol 72, Iss 2, Pp 324-331 (2023)
Background: Interleukin-33 (IL-33) is involved in type 2 innate immunity by inducing type 2 cytokines, such as IL-5 and IL-13, through the activation of group 2 innate lymphoid cells (ILC2s) or T helper 2 (Th2) cells. We previously reported that mice
Externí odkaz:
https://doaj.org/article/889a2bb459fe412e86256d8c7dd73278
Publikováno v:
Allergology International, Vol 72, Iss 2, Pp 234-244 (2023)
Biologics applying antibodies against IgE, IL-5, IL-5 receptor α, IL-4 receptor α, and IL-13 have dramatically improved recent treatment outcomes in allergic diseases including asthma, rhinitis, and atopic dermatitis. However, these drugs have not
Externí odkaz:
https://doaj.org/article/3b400253805e462ea3239f8ea7f7517f
Autor:
Dai Miyazaki, Atsuki Fukushima, Eiichi Uchio, Jun Shoji, Kenichi Namba, Nobuyuki Ebihara, Etsuko Takamura, Ken Fukuda, Akira Matsuda, Shigeki Okamoto, Kazumi Fukagawa, Hiroshi Fujishima, Shigeaki Ohno, Yuichi Ohashi
Publikováno v:
Allergology International, Vol 71, Iss 4, Pp 459-471 (2022)
Allergic conjunctival disease (ACD) is an inflammatory disease of the conjunctiva that is mainly caused by type I hypersensitivity response to allergens and accompanied by subjective symptoms and other findings induced by antigens. ACD is classified
Externí odkaz:
https://doaj.org/article/fb90eec82f3a4941a4cd44a6d845c1ce
Autor:
Mayumi Ueta, Hiromi Nishigaki, Seitaro Komai, Katsura Mizushima, Risa Tamagawa-Mineoka, Yuji Naito, Norito Katoh, Chie Sotozono, Shigeru Kinoshita
Publikováno v:
Frontiers in Genetics, Vol 13 (2023)
Background: We have hypothesized that different factors are involved in the severity of ACD and AD because some but not all patients with atopic dermatitis (AD) present with allergic conjunctival disease (ACD) including severe types such as atopic ke
Externí odkaz:
https://doaj.org/article/ea913ba62cb540d9b7bcc1716a36f96e
Autor:
Sara Sánchez-Tabernero, Julia Fajardo-Sanchez, Wynne Weston-Davies, Mohit Parekh, Jaime Kriman, Stephen Kaye, Sajjad Ahmad
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-6 (2021)
Abstract Purpose To evaluate the safety and preliminary efficacy of topical rVA576, a dual inhibitor of complement component 5 (C5) and leukotriene B4 (LTB4), in patients with recalcitrant atopic keratoconjunctivitis (AKC) in the open label phase 1 T
Externí odkaz:
https://doaj.org/article/6000a869e86f4ceba1b9ba4c2299cc92
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 17, Iss 1, Pp 1-9 (2021)
Abstract Background Because atopic dermatitis does not heal completely, associated severe atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) often require long-term treatment. This study aims to evaluate the long-term outcomes of
Externí odkaz:
https://doaj.org/article/7884d1499a0440c3bfcd052e7678a787